A variety of neuroprotectants have shown promise in treating ischemic stroke, yet their
delivery to the brain remains a challenge. The endothelial cells lining the blood-brain barrier …

With the rise in the aging global population, stroke comorbidities have become a serious
health threat and a tremendous economic burden on human society. Current therapeutic …

Multiple sclerosis (MS) is a chronic, inflammatory, and degenerative disease of the central
nervous system (CNS). Inflammation is observed in all stages of MS, both within and around …

Background Stroke, an acute cerebrovascular event, is a leading cause of disability, placing
a significant psycho-socioeconomic burden worldwide. The adaptation and reorganization …

Background and objectives: Brain-derived neurotrophic factor (BDNF) is one of the most
studied neurotrophins. Low BDNF concentrations have been noted in patients with …

Background Immersive virtual reality (VR)-based motor control training (VRT) is an
innovative approach to improve motor function in patients with stroke. Currently, outcome …

Cerebral stroke, which is one of the most frequent causes of mortality and leading cause of
disability in developed countries, often leads to devastating and irreversible brain damage …

Cognitive dysfunction is the most common nonphysical impairment in the stroke survivors.
This impairment has a negative impact on patients' quality of life affects their daily living …

Newborns suffering from perinatal arterial ischemic stroke (PAIS) are at risk of
neurodevelopmental problems. Current treatment options for PAIS are limited and mainly …

Background Physiological adaptations of stroke patients after high-intensity interval training
(HIIT) and moderate-intensity continuous training (MICT) remain unclear. Objective This …